PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Université de Paris, CRESS, INSERM, INRA, Paris, France.\', \'Centre d\'Epidémiologie Clinique, Hôpital Hôtel-Dieu, AP-HP, Paris, France.\', \'Assistance Publique Hôpitaux de Paris, Paris, France.\', \'Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA.\', \'Service d\'Accueil des Urgences, Hôpital Saint Antoine, AP-HP, Sorbonne Université, Paris,France.\', \'INSERM, Institut Pierre Louis d\'Epidémiologie et de Santé Publique, UMR-S, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciab352
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33912905
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Development and Validation of the Long Coronavirus Disease (COVID) Symptom and Impact Tools: A Set of Patient-Reported Instruments Constructed From Patients\' Lived Experience.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all